Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 07, 2023

SELL
$0.56 - $1.24 $2,800 - $6,200
-5,000 Reduced 20.83%
19,000 $13,000
Q4 2022

Jan 23, 2023

BUY
$0.83 - $2.26 $19,920 - $54,239
24,000 New
24,000 $0

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $47.1M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Capital Cs Group, LLC Portfolio

Follow Capital Cs Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Cs Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Cs Group, LLC with notifications on news.